Gene Query: SARM1

Dataset Description Geneva Score
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 56.95
IL-33 activates tumor stroma to promote intestinal polyposis 43.68
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 32.96
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 32.38
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 26.52
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 25.48
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 22.94
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 21.57
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 20.48
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 19.98
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 19.72
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 19.16
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 19.08
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 19.08
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 18.27
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 17.91
An integrative analysis of non-coding regulatory DNA variations associated with autism 17.17
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 15.14
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 14.61
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 14.59
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 14.36
RNAseq analysis of ESRP regulated splicing events in prostate cancer 14.17
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 13.55
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 13.55
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 13.51
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 13.32
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 13.32
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 12.79
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 12.67
DJ-1 is dispensable for human stem cell homeostasis 12.43
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 12.42
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 12.34
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 12.13
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 11.67
Global epigenomic reconfiguration during mammalian brain development 11.55
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 11.28
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 11.28
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 11.22
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 11.1
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 10.99
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 10.88
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 10.71
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 10.65
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 10.61
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 10.48
Glioblastoma stem cells infected by ZIKA virus 10.41
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 10.35
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 10.21
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 10.11
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 10.03
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 10.01
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 9.42
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 9.38
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 9.37
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 9.37
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 9.22
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 9.12
A prostate cancer chromatin interaction map 9.01
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 8.98
Transcriptional effect of ETV1 knockdown in melanoma cells 8.91
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 8.87
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 8.85
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 8.79
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 8.68
Examining serotonergic neuron differentiation from human iPSCs 8.67
The regulartory role of ZCCHC24 in splicing machinery 8.58
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 8.46
Dissecting neural differentiation regulatory networks through epigenetic footprinting 8.19
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 8.16
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 8.13
RNA-seq of human aneuploid cell lines with Trisomy 21 8.08
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 8.03
Inhibition of TNBC metastasis by Gpx1 7.9
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 7.88
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.85
N6-methyladenine DNA Modification in Glioblastoma 7.85
The MEF2B Regulatory Network - RNA-seq data 7.84
The MEF2B Regulatory Network 7.84
RNAseq Analysis in glioblastoma cells treated with Mepazine 7.83
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 7.77
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 7.64
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 7.62
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 7.62
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 7.45
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.43
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 7.41
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.38
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 7.35
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 7.35
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 7.32
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.3
RNA-seq analyses of human prostate cancer cells 7.18
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 7.13
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 7.1
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 7.07
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 7.04
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 7.02
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 6.98
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 6.97
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 6.96
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 6.89
DART-seq: an antibody-free method for global m6A detection 6.86
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 6.75
Effect of PRDM11 depletion in U2932 cells 6.73
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 6.62
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 6.62
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.58
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.58
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.48
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 6.41
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.39
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 6.34
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.29
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.29
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 6.25
LNCaP treated with iBET 6.25
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 6.2
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.19
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 6.12
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 6.12
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 6.11
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.01
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.01
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 5.96
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.95
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 5.86
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.82
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.8
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 5.73
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 5.73
Epigenomic landscape during organ formation in human early embryos 5.72
High-Throughput Kinetic Analysis of Fractional Killing 5.69
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.64
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 5.62
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.55
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 5.54
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 5.49
HEXIM1 is induced by DHODH inhibition to suppress melanoma 5.49
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.47
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.46
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.41
Transcriptome analysis of H9 hESC derived cerebral organoids 5.41
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 5.38
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 5.35
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.34
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.34
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.3
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.29
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 5.23
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.19
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.19
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 5.14
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 5.13
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.12
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 5.11
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 5.08
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 5.07
Dtx3L and Androgen Signaling in Prostate Cancer 5.04
RNA-seq analysis of uveal melanoma cells treated with FR900359 5.0
Gene expression changes in human melanoma cell lines compared to primary melanocytes 4.99
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.94
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 4.93
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 4.92
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 4.92
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 4.88
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 4.85
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 4.82
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 4.82
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.81
Functional astrocytes differentiated from hiPSCs 4.75
Gene expression changes after LOC550643 silencing 4.7
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 4.67
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 4.65
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 4.63
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.63
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 4.62
FGF2 regulation of gene expression in stable inducible Neurons 4.61
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 4.54
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 4.53
hTERT promotes cell adhesion and migration independent of telomerase activity 4.47
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 4.44
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 4.44
Identification of long noncoding RNAs in T-ALL cell lines 4.42
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 4.41
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 4.38
RNA sequencing of BT142 and TS603 cell lines 4.38
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.37
Lysine benzoylation is a novel histone mark [RNA-seq] 4.33
Lysine benzoylation is a novel histone mark 4.33
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.33
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 4.25
EP400 is required for Max and MCPyV mediated gene activation 4.19
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 4.19
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 4.16
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.15
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 4.14
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 4.07
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 4.07
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 4.07
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.07
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.07
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 4.05
Effect of CHKA knockdown on C4-2 cell transcriptome 4.01
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 4.0
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 3.98
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.96
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.95
HNRNPM-regulated splicing dependencies in prostate cancer 3.95
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 3.94
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 3.91
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 3.9
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.89
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.88
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.87
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 3.83
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 3.82
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 3.81
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.78
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 3.77
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 3.72
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 3.67
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 3.64
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.62
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.62
Transcriptome profiling of Normal and Cancerous Prostate Cells 3.61
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 3.58
NRDE2 negatively regulates nuclear exosome functions 3.56
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.55
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.54
Functional role of SLIT2 and ROBO1 in trophoblasts 3.46
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 3.45
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 3.45
Differential gene expression of human melanoma cells [RNA-seq] 3.44
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 3.44
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 3.43
Genome-wide chromatin analysis of Ewing sarcoma 3.43
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.43
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.43
Identification of global regulators of T-helper cell lineage specification 3.43
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.43
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.43
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.42
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 3.41
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 3.41
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 3.39
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 3.33
Differentiation enhances Zika virus infection in neuronal brain cells 3.33
MARS Seq data from human cortical organoids 3.29
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.28
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.23
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 3.19
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.18
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 3.17
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.13
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 3.1
Studying the selectivity of a small molecule Synucleozid on transcriptome 3.07
Entrectinib Resistance in a Neuroblastoma Xenograft Model 3.04
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 3.04
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 2.99
Analysis of transcriptional regulation by Myt1 and Myt1l 2.99
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 2.97
Engineering Patient-Specific Tissue Implants 2.95
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 2.93
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 2.93
RNA-seq analysis of RALD iPSCs after in vitro differentiation 2.91
Downregulation of DDX5/DDX17 and REST 2.91
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.9
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.88
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.86
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.84
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 2.77
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.76
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.73
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.72
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.72
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.67
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 2.67
Controlling for gene expression changes in transcription factor protein networks. 2.66
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.66
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.6
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.58
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.58
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.57
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 2.56
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.55
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.55
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.52
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 2.51
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 2.51
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.51
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.51
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 2.5
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 2.5
RNA sequencing of human pancreatic cancer cell lines 2.49
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.48
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 2.47
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 2.47
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.45
Total RNA sequencing of APC mutant and wt colonic organoids 2.43
UV_24h_GRO-Seq 2.42
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.42
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.42
Ribosomal protein RPL26 is the principal target of UFMylation 2.42
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.4
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.39
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.37
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.3
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 2.3
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.27
Global analysis of alternative splicing regulated by RBM10 2.27
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.26
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.24
Co-regulation of splicing by Rbfox1 and hnRNP M 2.24
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.24
RNA-Seq with and without RNase treatment in PCa cell lines 2.21
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.21
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.21
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.21
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.2
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.17
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.14
Enhancer activation during EGF response 2.13
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.13
Gene expression profile in breast cancer cell lines using RNA sequencing 2.13
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.09
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.06
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 2.04
Expression profiles of the four human major ectodermal lineages 2.04
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.01
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.01
RNA splicing alteration on glioblastoma and normal neural stem cells 1.99
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 1.99
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.98
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 1.98
Functional role of CPPED1 in trophoblasts. 1.96
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.95
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.93
RNA-seq of cancer cell lines treated with T-025 1.92
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.91
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.89
Gene expression analysis upon mtDNA depletion 1.89
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.87
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.87
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.87
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 1.86
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.85
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.79
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.77
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.77
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.74
RNA seq analysis of human Fetal and adult derived Enterospheres 1.73
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.69
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 1.68
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.67
Induced DNA demethylation, genome instability and transcription 1.67
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.66
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.65
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.64
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.62
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 1.62
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.6
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.6
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.59
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.58
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.58
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.56
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.56
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.55
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.54
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.54
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.54
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.52
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.52
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.51
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.5
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.5
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.49
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.49
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.47
X-Ray induced DNA-Hydroxymethylation changes 1.46
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.46
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.44
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.44
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.44
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.44
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.44
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.44
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.42
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.42
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 1.42
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.42
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.41
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.35
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.31
JAK dependent survival of ALK- ALCL 1.29
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 1.28
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.27
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.26
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.24
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.24
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.23
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.23
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.23
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.23
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.23
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 1.22
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 1.19
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 1.19
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.15
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.14
hESC neural differentiation 1.14
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.11
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.08
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.07
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.07
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.07
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 1.06
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.05
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 1.05
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.05
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 1.04
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.03
RNA-seq of SCLC PDX models treated with EP 1.02
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.02
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.94
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.94
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 0.94
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.93
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.92
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.91
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.9
The cohesin release factor WAPL restricts chromatin loop extension. 0.9
Identification of global XBP1s target gene expression in human prostate cancer cells 0.9
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.89
Positively selected enhancer elements endow tumor cells with metastatic competence 0.88
Polarized B -cell functions 0.88
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.86
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.86
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 0.84
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 0.84
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.82
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.75
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 0.74
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 0.74
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.71
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.7
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.65
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.65
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.63
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.6
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.58
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.58
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.58
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.57
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.56
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.56
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.54
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.5
RNAseq of T-ALL upon long non coding rna purturbation 0.49
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.49
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.49
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.44
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.42
RNA-seq in endometrial stromal tumors 0.39
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.39
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.38
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.37
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.32
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.3
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.29
Function and hormonal regulation of GATA3 in human first trimester placentation 0.29
Role of FGFR1 in neuronal devlopment 0.28
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.26
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.25
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.25
Leucegene: ALL sequencing 0.25
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.24
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.21
The role of m6A/m-RNA methylation in stress response regulation 0.21
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.21
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.2
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.19
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.19
Zika virus directly infects human peripheral neurons and induces cell death 0.17
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.16
hNSCs siRNA NOVA2 0.16
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.12
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.12
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.07
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.05
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.04
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.03
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.03
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.03
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.03
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.01
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.01
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation